Sarepta Therapeutics, Inc. · NASDAQ:SRPT

Severino Michael received 756,104 Sarepta Therapeutics, Inc. shares as an award (Form 4)

Traded Jul 28, 2026 · Filed Jul 29, 2026

On Jul 28, 2026, Severino Michael (Director, Chief Executive Officer) received 756,104 Sarepta Therapeutics, Inc. shares as an award, leaving 756,104 shares. Filed Jul 29, 2026 (Form 4).

Awarded
756,104 shares
Holding after
756,104 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 28, 2026Common StockAward756,104756,104Direct

Source

View original at SEC

Related